Parkinson’s Disease Therapeutics Market Report

Global and China Parkinson’s Disease Therapeutics Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 22, 2022
  • PAGES：183
  • REPORT CODE：GMM1396896
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Parkinson’s Disease Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Orion Corporation

    • GlaxoSmithKline

    • Biogen

    • Newron Pharmaceuticals SpA

    • Teva Pharmaceutical Industries Ltd

    • Abbvie

    • F Hoffman-La Roche

    • H Lundbeck A/S

    • Novartis AG

    • UCB SA

    • Boehringer Ingelheim GmbH

    • Impax Labs

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Oral

    • Transdermal

    • Subcutaneous

    • Intestinal Infusion

    Application:

    • Hospitals

    • Clinics

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Parkinson’s Disease Therapeutics Industry Overview

      • 1.1.1 Parkinson’s Disease Therapeutics Market Scope and Market Segments

      • 1.1.2 Parkinson’s Disease Therapeutics Industry Characteristics

      • 1.1.3 Global and China Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Parkinson’s Disease Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Parkinson’s Disease Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Oral

      • 1.2.2 Transdermal

      • 1.2.3 Subcutaneous

      • 1.2.4 Intestinal Infusion

    • 1.3 Global Parkinson’s Disease Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Parkinson’s Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Parkinson’s Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Parkinson’s Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Parkinson’s Disease Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Parkinson’s Disease Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Parkinson’s Disease Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Parkinson’s Disease Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Parkinson’s Disease Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Parkinson’s Disease Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Parkinson’s Disease Therapeutics Industry PEST Analysis

    • 2.3 Parkinson’s Disease Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Parkinson’s Disease Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Parkinson’s Disease Therapeutics Industry

    Chapter 3 Global and China Parkinson’s Disease Therapeutics Market, by Manufacturer

    • 3.1 Global and China Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Parkinson’s Disease Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Parkinson’s Disease Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Parkinson’s Disease Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Parkinson’s Disease Therapeutics Market Top 3 Players

    Chapter 4 Global and China Parkinson’s Disease Therapeutics Market, by Type (2017-2028)

    • 4.1 Parkinson’s Disease Therapeutics Market Trend, by Type

    • 4.2 Global Parkinson’s Disease Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Parkinson’s Disease Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Parkinson’s Disease Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Parkinson’s Disease Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Parkinson’s Disease Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Parkinson’s Disease Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Parkinson’s Disease Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Parkinson’s Disease Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Parkinson’s Disease Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Parkinson’s Disease Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Parkinson’s Disease Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Parkinson’s Disease Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Parkinson’s Disease Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Parkinson’s Disease Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Parkinson’s Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Parkinson’s Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Parkinson’s Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Parkinson’s Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Parkinson’s Disease Therapeutics Market Analysis

    • 7.1 North America Parkinson’s Disease Therapeutics Market, by Type

    • 7.2 North America Parkinson’s Disease Therapeutics Market, by Application

    • 7.3 North America Parkinson’s Disease Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Parkinson’s Disease Therapeutics Market Analysis

    • 8.1 Europe Parkinson’s Disease Therapeutics Market, by Type

    • 8.2 Europe Parkinson’s Disease Therapeutics Market, by Application

    • 8.3 Europe Parkinson’s Disease Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Parkinson’s Disease Therapeutics Market Analysis

    • 9.1 APAC Parkinson’s Disease Therapeutics Market, by Type

    • 9.2 APAC Parkinson’s Disease Therapeutics Market, by Application

    • 9.3 APAC Parkinson’s Disease Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Parkinson’s Disease Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Parkinson’s Disease Therapeutics Company Profiles

      • 11.1 Orion Corporation

        • 11.1.1 Orion Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Orion Corporation Parkinson’s Disease Therapeutics Product Profiles, Application and Specification

        • 11.1.3 Orion Corporation Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 GlaxoSmithKline

        • 11.2.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Profiles, Application and Specification

        • 11.2.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Biogen

        • 11.3.1 Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Biogen Parkinson’s Disease Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Biogen Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Newron Pharmaceuticals SpA

        • 11.4.1 Newron Pharmaceuticals SpA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Teva Pharmaceutical Industries Ltd

        • 11.5.1 Teva Pharmaceutical Industries Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Teva Pharmaceutical Industries Ltd Parkinson’s Disease Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Teva Pharmaceutical Industries Ltd Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Abbvie

        • 11.6.1 Abbvie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Abbvie Parkinson’s Disease Therapeutics Product Profiles, Application and Specification

        • 11.6.3 Abbvie Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 F Hoffman-La Roche

        • 11.7.1 F Hoffman-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 F Hoffman-La Roche Parkinson’s Disease Therapeutics Product Profiles, Application and Specification

        • 11.7.3 F Hoffman-La Roche Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 H Lundbeck A/S

        • 11.8.1 H Lundbeck A/S Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 H Lundbeck A/S Parkinson’s Disease Therapeutics Product Profiles, Application and Specification

        • 11.8.3 H Lundbeck A/S Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Novartis AG

        • 11.9.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Novartis AG Parkinson’s Disease Therapeutics Product Profiles, Application and Specification

        • 11.9.3 Novartis AG Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 UCB SA

        • 11.10.1 UCB SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 UCB SA Parkinson’s Disease Therapeutics Product Profiles, Application and Specification

        • 11.10.3 UCB SA Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Boehringer Ingelheim GmbH

        • 11.11.1 Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Profiles, Application and Specification

        • 11.11.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Impax Labs

        • 11.12.1 Impax Labs Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Impax Labs Parkinson’s Disease Therapeutics Product Profiles, Application and Specification

        • 11.12.3 Impax Labs Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Parkinson’s Disease Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Parkinson’s Disease Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Parkinson’s Disease Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Parkinson’s Disease Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Market Size and Growth Rate of Oral (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Market Size and Growth Rate of Transdermal (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Market Size and Growth Rate of Subcutaneous (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Market Size and Growth Rate of Intestinal Infusion (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Parkinson’s Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Parkinson’s Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Parkinson’s Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Parkinson’s Disease Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Parkinson’s Disease Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Parkinson’s Disease Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Parkinson’s Disease Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Parkinson’s Disease Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Parkinson’s Disease Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Parkinson’s Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Parkinson’s Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Parkinson’s Disease Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Parkinson’s Disease Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Price Trend, by Type (2017-2028)

    • Table China Parkinson’s Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Parkinson’s Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Parkinson’s Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Parkinson’s Disease Therapeutics Sales Value, by Type (2017-2028)

    • Table China Parkinson’s Disease Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Parkinson’s Disease Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Parkinson’s Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Parkinson’s Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Parkinson’s Disease Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Parkinson’s Disease Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Parkinson’s Disease Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Parkinson’s Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Parkinson’s Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson’s Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Parkinson’s Disease Therapeutics Sales Value, by Application (2017-2028)

    • Table China Parkinson’s Disease Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson’s Disease Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson’s Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Parkinson’s Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Parkinson’s Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Parkinson’s Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Parkinson’s Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Parkinson’s Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Parkinson’s Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Parkinson’s Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Parkinson’s Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Parkinson’s Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Parkinson’s Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Parkinson’s Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Parkinson’s Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Parkinson’s Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Parkinson’s Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Parkinson’s Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Parkinson’s Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Parkinson’s Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Parkinson’s Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Parkinson’s Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Parkinson’s Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Parkinson’s Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson’s Disease Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Parkinson’s Disease Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Parkinson’s Disease Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Orion Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Orion Corporation Product Profiles, Application and Specification

    • Table Orion Corporation Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biogen Product Profiles, Application and Specification

    • Table Biogen Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Newron Pharmaceuticals SpA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Newron Pharmaceuticals SpA Product Profiles, Application and Specification

    • Table Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceutical Industries Ltd Product Profiles, Application and Specification

    • Table Teva Pharmaceutical Industries Ltd Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbvie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbvie Product Profiles, Application and Specification

    • Table Abbvie Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffman-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffman-La Roche Product Profiles, Application and Specification

    • Table F Hoffman-La Roche Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table H Lundbeck A/S Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table H Lundbeck A/S Product Profiles, Application and Specification

    • Table H Lundbeck A/S Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table UCB SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table UCB SA Product Profiles, Application and Specification

    • Table UCB SA Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim GmbH Product Profiles, Application and Specification

    • Table Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Impax Labs Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Impax Labs Product Profiles, Application and Specification

    • Table Impax Labs Parkinson’s Disease Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US